BMY

BRISTOL-MYERS SQUIBB CO

BMY·110122108·US·Common Stock·Healthcare - Drug Manufacturers - General-13D/G

BMY (BRISTOL-MYERS SQUIBB CO) is held by 340 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($10.4B), VANGUARD CAPITAL MANAGEMENT LLC ($7.7B), STATE STREET CORP ($5.9B). Net institutional sentiment: Mixed.

340
Holders
(35 Elite)
$84.4B
Total Value
52% (347)
Consensus
182 buying - 165 selling
13F: Insider & Congress: Updated regularly
BMY

Smart Money Verdict

View all
Loading verdict
Held by 340 funds
35 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 26, 2026 · Activists Aug 7, 2026 · Congress none

InsiderHMHolzer Phil MSell $34KAug 25, 2026
ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION5.0%Aug 7, 2026
InsiderLALenkowsky AdamExercise 1K shMay 1, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
180.4M(+5.1%)$10.4B0.2%+28.55%
40
Increased
133.3M(+0.8%)$7.7B0.2%+12.20%
38
Increased
102.4M(+3.9%)$5.9B0.2%+45.21%
40
Decreased
71.7M(-22.4%)$4.2B0.2%+31.12%
0
Increased
67.6M(+10.6%)$3.9B0.5%+42.20%
50
Increased
56.4M(+2.1%)$3.2B0.2%+37.31%
39
Increased
46.9M(+1.4%)$2.7B0.1%+12.22%
39
Increased
34M(+4.5%)$2B0.1%+18.51%
40
Decreased
29M(-0.7%)$1.7B0.1%+63.18%
0
Decreased
27.4M(-7.7%)$1.6B0.5%+28.51%
0
Increased
26.7M(+0.8%)$1.5B0.3%+45.98%
38
Decreased
24.9M(-0.3%)$1.4B0.8%+56.28%
0
Increased
24.9M(+0.6%)$1.4B0.2%+54.46%
38
Increased
22.8M(+0.5%)$1.3B0.2%+43.88%
38
Decreased
21.8M(-6.3%)$1.3B0.2%+31.59%
0
Increased
21.8M(+2.4%)$1.3B8.2%+40.08%
64
Increased
19.7M(+5.0%)$1.1B0.2%+25.21%
40
Increased
17M(+0.9%)$980.9M0.2%+46.17%
38
Increased
17M(+21.1%)$980.5M0.1%+30.56%
38
Decreased
17M(-0.5%)$979.9M2.9%+35.35%
0

Showing 1-20 of 351

1 / 18
BMYBMYBRISTOL-MYERS SQUIBB CO

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used